UW Spin-out PhysioSonics Gets FDA Approval for Monitoring Brain Blood Flow
PhysioSonics, a UW spin-out company founded in 2000 by Robert Frederickson, Michel Kliot, Pierre Mourad, and Jeffrey Jarvik, has won approval from the FDA to start selling its Presto 1000 Flow Monitor system in the U.S., according to CEO Brad Harlow.
The technology automates the way technicians and physicians monitor blood flow in the brain. Instead of having a technician manually hold an ultrasound transducer up against the head of a patient suffering from a stroke, an aneurysm, vasospasms, or traumatic brain injury, the PhysioSonics system allows continuous automated monitoring.
Read the full story in Xconomy